Selected 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors. A look into their use and potential in pre-diabetes and type 2 diabetes

Objectives. This review assesses the comparative safety and efficacy of selected 3-hydroxy-3-methylglutaric acid coenzyme A inhibitors (statins, cinnamic acids. 3-hydroxy-3-methyl glutaric acid) on the pre-onset type 2 diabetes (PT2D) and post-onset type 2 diabetes (T2D)-related cluster of seven fea...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Barre Douglas Edward, Mizier-Barre Kazimiera Amelia
Formato:	article
Lenguaje:	EN
Publicado:	Sciendo 2021
Materias:	statins flaxseed lignan complex cinnamic acids 3-hydroxy-3-methylglutaric acid 3-hydroxy-3-methylglutaric acid coenzyme a reductase inhibition type 2 diabetes mellitus central obesity hyperglycemia hypertension dyslipidemia pro-thrombosis oxidation and inflammation Diseases of the endocrine glands. Clinical endocrinology RC648-665
Acceso en línea:	https://doaj.org/article/47bfd362d0fe4b27882c534ed192c1a5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:47bfd362d0fe4b27882c534ed192c1a5
record_format	dspace
spelling	oai:doaj.org-article:47bfd362d0fe4b27882c534ed192c1a52021-12-02T17:37:18ZSelected 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors. A look into their use and potential in pre-diabetes and type 2 diabetes1336-032910.2478/enr-2021-0020https://doaj.org/article/47bfd362d0fe4b27882c534ed192c1a52021-07-01T00:00:00Zhttps://doi.org/10.2478/enr-2021-0020https://doaj.org/toc/1336-0329Objectives. This review assesses the comparative safety and efficacy of selected 3-hydroxy-3-methylglutaric acid coenzyme A inhibitors (statins, cinnamic acids. 3-hydroxy-3-methyl glutaric acid) on the pre-onset type 2 diabetes (PT2D) and post-onset type 2 diabetes (T2D)-related cluster of seven features (central obesity, hyperglycemia, hypertension, dyslipidemia, pro-thrombosis, oxidation and inflammation).Barre Douglas EdwardMizier-Barre Kazimiera AmeliaSciendoarticlestatinsflaxseed lignan complexcinnamic acids3-hydroxy-3-methylglutaric acid3-hydroxy-3-methylglutaric acid coenzyme a reductase inhibitiontype 2 diabetes mellituscentral obesityhyperglycemiahypertensiondyslipidemiapro-thrombosisoxidation and inflammationDiseases of the endocrine glands. Clinical endocrinologyRC648-665ENEndocrine Regulations, Vol 55, Iss 3, Pp 182-192 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	statins flaxseed lignan complex cinnamic acids 3-hydroxy-3-methylglutaric acid 3-hydroxy-3-methylglutaric acid coenzyme a reductase inhibition type 2 diabetes mellitus central obesity hyperglycemia hypertension dyslipidemia pro-thrombosis oxidation and inflammation Diseases of the endocrine glands. Clinical endocrinology RC648-665
spellingShingle	statins flaxseed lignan complex cinnamic acids 3-hydroxy-3-methylglutaric acid 3-hydroxy-3-methylglutaric acid coenzyme a reductase inhibition type 2 diabetes mellitus central obesity hyperglycemia hypertension dyslipidemia pro-thrombosis oxidation and inflammation Diseases of the endocrine glands. Clinical endocrinology RC648-665 Barre Douglas Edward Mizier-Barre Kazimiera Amelia Selected 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors. A look into their use and potential in pre-diabetes and type 2 diabetes
description	Objectives. This review assesses the comparative safety and efficacy of selected 3-hydroxy-3-methylglutaric acid coenzyme A inhibitors (statins, cinnamic acids. 3-hydroxy-3-methyl glutaric acid) on the pre-onset type 2 diabetes (PT2D) and post-onset type 2 diabetes (T2D)-related cluster of seven features (central obesity, hyperglycemia, hypertension, dyslipidemia, pro-thrombosis, oxidation and inflammation).
format	article
author	Barre Douglas Edward Mizier-Barre Kazimiera Amelia
author_facet	Barre Douglas Edward Mizier-Barre Kazimiera Amelia
author_sort	Barre Douglas Edward
title	Selected 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors. A look into their use and potential in pre-diabetes and type 2 diabetes
title_short	Selected 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors. A look into their use and potential in pre-diabetes and type 2 diabetes
title_full	Selected 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors. A look into their use and potential in pre-diabetes and type 2 diabetes
title_fullStr	Selected 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors. A look into their use and potential in pre-diabetes and type 2 diabetes
title_full_unstemmed	Selected 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors. A look into their use and potential in pre-diabetes and type 2 diabetes
title_sort	selected 3-hydroxy-3-methyl-glutaryl-coenzyme a reductase inhibitors. a look into their use and potential in pre-diabetes and type 2 diabetes
publisher	Sciendo
publishDate	2021
url	https://doaj.org/article/47bfd362d0fe4b27882c534ed192c1a5
work_keys_str_mv	AT barredouglasedward selected3hydroxy3methylglutarylcoenzymeareductaseinhibitorsalookintotheiruseandpotentialinprediabetesandtype2diabetes AT mizierbarrekazimieraamelia selected3hydroxy3methylglutarylcoenzymeareductaseinhibitorsalookintotheiruseandpotentialinprediabetesandtype2diabetes
_version_	1718379879824621568

Selected 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitors. A look into their use and potential in pre-diabetes and type 2 diabetes

Ejemplares similares